User:Tkadm30/Notebook/THC: Difference between revisions
(New page: Sweet Marijane, Before the dawn of ages you have cured the afflicted from mental oppression, We have learned to cultivate you even you were repressed from repressors of the truth, We h...) |
m (Yar moved page User:Etienne Robillard/Notebook/THC to User:Tkadm30/Notebook/THC: Automatically moved page while renaming the user "Etienne Robillard" to "Tkadm30") |
||
(112 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
'''This page has moved [https://www.isotoperesearch.ca/wiki/index.php?title=THC here]''' | |||
__TOC__ | |||
===Synopsis=== | |||
* Delta(9)-tetrahydrocannabinol (THC) is the main psychoactive constituent of the Cannabis sativa L (Marijuana) plant. | |||
* Others marijuana-derived cannabinoids includes Cannabichromene (CBC), Cannabidiol (CBD), Cannabinol (CBN), Cannabigerol (CBG), and Tetrahydrocannabivarin (THCV). | |||
* Marijuana-derived cannabinoids are known as phytocannabinoids. | |||
* THCA is the biosynthetic precursor of THC. | |||
===Antidepressant properties of THC=== | |||
* THC may stimulate anandamide mobilization(?) by binding to the CB1 receptor, thus producing a antidepressant and neuroprotective effect. <cite>Website2</cite> | |||
===Neuroprotective properties of THC=== | |||
====Alzheimer==== | |||
* THC may inhibit acetylcholinesterase-induced intraneuronal amyloid beta aggregation in Alzheimer's disease. <cite>Eubanks-2006</cite> | |||
* THC may prevent intracellular amyloid beta proteotoxicity and inflammatory response. <cite>Website4</cite> | |||
====Drug-induced dopamine supersensitivity==== | |||
* THC is high-affinity dopamine agonist for reversing drug-induced dopamine supersensitivity. <cite>Pope-2010</cite> | |||
====Cognitive aging==== | |||
* THC may reverse the cognitive aging process in the brain. (Reference needed) | |||
====Glaucoma==== | |||
* THC may reduce intraocular pressure (IOP) in retinal ganglion cells (RGCs) through intracellular CB1 receptor activation. | |||
** A potential treatment for glaucoma to prevent optic nerve damage. | |||
====Tardive diskinesia==== | |||
* [https://www.mrnice.nl/forum/9-patients-forum/15850-cannabinoids-prevention-management-tardive-diskinesia.html Cannabinoids for prevention and management of tardive diskinesia?] | |||
====Traumatic brain injury==== | |||
* Do THC exert a neuroprotective effect on TBI? | |||
** Review: https://www.ncbi.nlm.nih.gov/pubmed/25264643 | |||
====Posttraumatic stress disorder==== | |||
* THC may reduce chronic nightmares frequency and alter dreaming activity? | |||
====Sleep regulation==== | |||
* THC may affect REM-sleep rebound. <cite>Murillo-2003</cite> | |||
* THC may reduce REM-sleep and increase slow wave sleep (SWS). | |||
===Effects of THC on neurogenesis, synaptogenesis and BDNF signaling=== | |||
* Hippocampal CB1 receptors regulate stress-induced neuroinflammation in the hippocampus. <cite>Zoppi-2011</cite> | |||
* THC enhance adult hippocampal neurogenesis and BDNF signaling through intracellular CB1 receptor activation. <cite>Jiang-2005</cite><cite>Campbell-2007</cite> | |||
* Intracellular CB1 activation promote neuronal cell proliferation, differentiation, maturation, and neurite growth. <cite>Xapelli-2013</cite> | |||
===Neuropsychology of THC tolerance=== | |||
* CB1 receptor sensitization can be restored by taking breaks of oral THC administration. (Reference needed) | |||
* Alcohol increase THC levels in blood. (Reference needed) | |||
* THC tolerance is genetic and regulated by the AKT1 gene. | |||
===Notes=== | |||
* THC may increase serotonergic tone. <cite>Nutt-2011</cite> | |||
* '''Possible cross-talk between dopaminergic vitamin D, delta9-THC, and endogenous cannabinoids (anandamide) ?''' | |||
===Experimental=== | |||
* Endogenous retrograde trafficking may promote hippocampal development (neurogenesis) and synaptogenesis. | |||
* Arachidonic acid/DHA levels affect neural stem/progenitor cells (NSPCs) proliferation in the hippocampus. (Reference needed) | |||
* THC may enhance corticostriatal functional connectivity though increased c-Fos expression. <cite>Todd-2016</cite> | |||
* Long-term THC administration may depletes melatonin synthesis. | |||
---- | ===References=== | ||
<biblio> | |||
#Eubanks-2006 https://www.ncbi.nlm.nih.gov/pubmed/17140265 | |||
//A molecular link between the active component of marijuana and Alzheimer's disease pathology. | |||
#Pope-2010 https://www.ncbi.nlm.nih.gov/pubmed/19969019 | |||
//Endocannabinoid signaling in neurotoxicity and neuroprotection. | |||
#Jiang-2005 https://www.ncbi.nlm.nih.gov/pubmed/16224541 | |||
//Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. | |||
#Campbell-2007 https://www.ncbi.nlm.nih.gov/pubmed/17828287 | |||
//Alzheimer's disease; taking the edge off with cannabinoids? | |||
#Xapelli-2013 https://www.ncbi.nlm.nih.gov/pubmed/23704915 | |||
//Activation of type 1 cannabinoid receptor (CB1R) promotes neurogenesis in murine subventricular zone cell cultures. | |||
#Zoppi-2011 https://www.ncbi.nlm.nih.gov/pubmed/21150911 | |||
//Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. | |||
#Website2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/ | |||
//Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. | |||
#Website4 http://www.nature.com/articles/npjamd201612 | |||
//Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. | |||
#Xiong-2011 https://www.ncbi.nlm.nih.gov/pubmed/21460829 | |||
//Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. | |||
#Gorzo-2017 https://www.ncbi.nlm.nih.gov/pubmed/28481360 | |||
//A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice. | |||
#Nutt-2011 https://www.ncbi.nlm.nih.gov/pubmed/22045940 | |||
//Low serotonergic tone and elevated risk for substance misuse. | |||
#Todd-2016 https://www.ncbi.nlm.nih.gov/pubmed/26377899 | |||
//Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis. | |||
#Nguyen-2014 https://www.ncbi.nlm.nih.gov/pubmed/25264643 | |||
//Effect of marijuana use on outcomes in traumatic brain injury. | |||
#Murillo-2003 https://www.ncbi.nlm.nih.gov/pubmed/12895525 | |||
//Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. | |||
</biblio> | |||
[[User: | ===See also=== | ||
* [[User:Etienne_Robillard/Notebook/AKT1|AKT1 Notebook]] | |||
* [[User:Etienne_Robillard/Notebook/TRPV1|TRPV1 Notebook]] | |||
* [[User:Etienne_Robillard/Notebook/THCV|THCV Notebook]] | |||
* [[User:Etienne_Robillard/Notebook/Endocannabinoids|Endocannabinoids Notebook]] | |||
* [https://en.wikipedia.org/wiki/Cannabinoid Cannabinoid] | |||
* [https://en.wikipedia.org/wiki/Tetrahydrocannabinol Tetrahydrocannabinol] | |||
* [https://en.wikipedia.org/wiki/Tetrahydrocannabinolic_acid THCA] | |||
* [https://www.thenakedscientists.com/forum/index.php?topic=65952.0 What are the effects of THC tolerance?] |
Latest revision as of 14:58, 2 October 2018
This page has moved here
Synopsis
- Delta(9)-tetrahydrocannabinol (THC) is the main psychoactive constituent of the Cannabis sativa L (Marijuana) plant.
- Others marijuana-derived cannabinoids includes Cannabichromene (CBC), Cannabidiol (CBD), Cannabinol (CBN), Cannabigerol (CBG), and Tetrahydrocannabivarin (THCV).
- Marijuana-derived cannabinoids are known as phytocannabinoids.
- THCA is the biosynthetic precursor of THC.
Antidepressant properties of THC
- THC may stimulate anandamide mobilization(?) by binding to the CB1 receptor, thus producing a antidepressant and neuroprotective effect. [1]
Neuroprotective properties of THC
Alzheimer
- THC may inhibit acetylcholinesterase-induced intraneuronal amyloid beta aggregation in Alzheimer's disease. [2]
- THC may prevent intracellular amyloid beta proteotoxicity and inflammatory response. [3]
Drug-induced dopamine supersensitivity
- THC is high-affinity dopamine agonist for reversing drug-induced dopamine supersensitivity. [4]
Cognitive aging
- THC may reverse the cognitive aging process in the brain. (Reference needed)
Glaucoma
- THC may reduce intraocular pressure (IOP) in retinal ganglion cells (RGCs) through intracellular CB1 receptor activation.
- A potential treatment for glaucoma to prevent optic nerve damage.
Tardive diskinesia
Traumatic brain injury
- Do THC exert a neuroprotective effect on TBI?
Posttraumatic stress disorder
- THC may reduce chronic nightmares frequency and alter dreaming activity?
Sleep regulation
- THC may affect REM-sleep rebound. [5]
- THC may reduce REM-sleep and increase slow wave sleep (SWS).
Effects of THC on neurogenesis, synaptogenesis and BDNF signaling
- Hippocampal CB1 receptors regulate stress-induced neuroinflammation in the hippocampus. [6]
- THC enhance adult hippocampal neurogenesis and BDNF signaling through intracellular CB1 receptor activation. [7][8]
- Intracellular CB1 activation promote neuronal cell proliferation, differentiation, maturation, and neurite growth. [9]
Neuropsychology of THC tolerance
- CB1 receptor sensitization can be restored by taking breaks of oral THC administration. (Reference needed)
- Alcohol increase THC levels in blood. (Reference needed)
- THC tolerance is genetic and regulated by the AKT1 gene.
Notes
- THC may increase serotonergic tone. [10]
- Possible cross-talk between dopaminergic vitamin D, delta9-THC, and endogenous cannabinoids (anandamide) ?
Experimental
- Endogenous retrograde trafficking may promote hippocampal development (neurogenesis) and synaptogenesis.
- Arachidonic acid/DHA levels affect neural stem/progenitor cells (NSPCs) proliferation in the hippocampus. (Reference needed)
- THC may enhance corticostriatal functional connectivity though increased c-Fos expression. [11]
- Long-term THC administration may depletes melatonin synthesis.
References
-
Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
-
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
-
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
-
Endocannabinoid signaling in neurotoxicity and neuroprotection.
-
Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound.
-
Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.
-
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.
-
Alzheimer's disease; taking the edge off with cannabinoids?
-
Activation of type 1 cannabinoid receptor (CB1R) promotes neurogenesis in murine subventricular zone cell cultures.
-
Low serotonergic tone and elevated risk for substance misuse.
-
Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
-
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.
-
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice.
-
Effect of marijuana use on outcomes in traumatic brain injury.